Comparing Remodulin vs Tyvaso DPI
| Remodulin (treprostinil) | Tyvaso DPI (treprostinil) |
|
|---|
| Remodulin (treprostinil) | Tyvaso DPI (treprostinil) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pulmonary Arterial Hypertension. Remodulin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pulmonary Arterial Hypertension. Tyvaso DPI may also be used for purposes not listed in this medication guide. |
||||||||
| More about Remodulin (treprostinil) | More about Tyvaso DPI (treprostinil) | ||||||||
| Ratings & Reviews | |||||||||
|
Remodulin has an average rating of 6.6 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 14% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Remodulin side effects |
View all Tyvaso DPI side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Remodulin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other treprostinil brands include: Orenitram, Tyvaso, Tyvaso DPI | Other treprostinil brands include: Orenitram, Remodulin, Tyvaso | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
4 hours |
4 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
Treprostinil (Remodulin, Tyvaso)
Category C
Risk cannot be ruled out
Treprostinil Oral (Orenitram) See the full pregnancy warnings document. |
Category B
No proven risk in humans
Treprostinil (Remodulin, Tyvaso)
Category C
Risk cannot be ruled out
Treprostinil Oral (Orenitram) See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 326 drugs are known to interact with Remodulin:
|
A total of 326 drugs are known to interact with Tyvaso DPI:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
May 23, 2022 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.